|
IL10RB expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.17400000000523E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.086300E-02 |
| Normal-vs-Stage2 |
4.87639999491307E-08 |
| Normal-vs-Stage3 |
3.58520000000029E-05 |
| Normal-vs-Stage4 |
4.364500E-04 |
| Stage1-vs-Stage2 |
3.93149999999842E-06 |
| Stage1-vs-Stage3 |
3.459200E-03 |
| Stage1-vs-Stage4 |
1.960000E-02 |
| Stage2-vs-Stage3 |
3.708000E-02 |
| Stage2-vs-Stage4 |
7.278200E-02 |
| Stage3-vs-Stage4 |
9.296600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.170180E-04 |
| Normal-vs-AfricanAmerican |
7.781100E-04 |
| Normal-vs-Asian |
3.335400E-01 |
| Caucasian-vs-AfricanAmerican |
4.150000E-01 |
| Caucasian-vs-Asian |
9.84200000000435E-05 |
| AfricanAmerican-vs-Asian |
9.751600E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.701300E-03 |
| Normal-vs-Female |
7.69300000000861E-05 |
| Male-vs-Female |
6.224400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099210E-01 |
| Normal-vs-Age(41-60Yrs) |
1.954900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.16420000306761E-08 |
| Normal-vs-Age(81-100Yrs) |
2.629800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.144260E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.03929999950969E-07 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.007600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.699500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.951800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.137400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.018100E-02 |
| Classical-VS-Follicular |
1.78200000000572E-06 |
| Classical-VS-Other |
4.967400E-01 |
| Classical-VS-Normal |
1.201930E-02 |
| Tall-VS-Follicular |
7.422000E-02 |
| Tall-VS-Other |
9.556600E-01 |
| Tall-VS-Normal |
4.805300E-04 |
| Follicular-VS-Other |
4.217400E-01 |
| Follicular-VS-Normal |
1.85120000439909E-08 |
| Other-VS-Normal |
3.062600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70304999999038E-05 |
| Normal-vs-N1 |
7.217200E-04 |
| N0-vs-N1 |
8.800800E-01 |
|
|
